Abstract Submission is Now Open!

• Taxonomy
• Animal Models and Papillomaviruses
• Immunology
• Regulation of Gene Expression, Post-transcriptional Modification
• Transformation and Carcinogenesis
• Structural Biology
• Virus – Host Interactions
• Virus Life Cycle
• Genomics of HPV-Associated Disease
• Papillomavirus Vaccines: Basic Science aspects
• Beta and Gamma Cutaneous HPV Infection, Biology, and Natural History
• Microbiome

• Self-Sampling to support screening New Technologies for Cervical Screening
• HPV tests and Biomarkers for Early Detection and Management of Cervical Cancer and Related Precursors
• Diagnosis and Management of HPV-Related Anogenital Cancers Other Than Cervix: Penile, Vaginal, Vulvar and Urological Cancer and Related Precursors
• Biomarkers for Early Detection and Management of non-cervical anogenital disease
• Diagnosis and Management of Anal Cancer and Related Precursors: Screening, Diagnosis and Management
• Diagnosis and Management of HPV-Related Oropharyngeal & Head and Neck Cancer
• Diagnosis and Management of Genital and Cutaneous Warts
• Diagnosis and Management of Cutaneous Warts and Other Skin Lesions
• Prophylactic Vaccines – Clinical Aspects
• Therapeutic Vaccines – Clinical Aspects
• Diagnosis and Management of HPV Disease in People Living with HIV and Other Forms of Immunocompromise
• Screening, Diagnosis and Treatment of Cervical Precancer in Low-Resource Settings
• Novel excisional/ablative treatments for HPV associated disease
• Novel Therapeutic Approaches to Treatment of HPV-Related Disease Including Antivirals
• Rapid assays for the detection of HPV-Related Disease
• Recurrent Respiratory Papillomatosis
• HPV NAAT Screening Quality Control/Assurance Guidelines
• Other Clinical Research

• Epidemiology: Natural History/Risk Factors (female) and/or (male)
• HPV among high risk/special populations
• Screening for HPV-Related Disease: Implementation, Evaluation and Impact
• Vaccination: Implementation, Evaluation and Impact
• Economics and Mathematical Modelling
• Cervical Cancer Elimination
• Head and Neck Cancers
• Vaccine Safety
• Impacts of COVID-19 Pandemic on HPV Vaccination Implementation & Public Health Aspects of HPV Screening
• Behavioral Science Aspects of New Technologies in Cervical Screening Including Dissemination/Communication Research
• Other Public Health, Epidemiology and Implementation Science Research